Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challengesConor A. Bradley, Sandra Van Schaeybroeck, Manuel Salto‐Tellez et al.|Nature Reviews Clinical Oncology|2017Cited by 241
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agentsPaul B. Mullan, D. Paul Harkin, Jennifer E. Quinn et al.|Oncogene|2001Cited by 153
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trialJ Cassidy, L. Garrison, J.-Y. Douillard et al.|British Journal of Cancer|2006Cited by 125
Prognostic importance of thymidylate synthase expression in early breast cancer.Bernhard C. Pestalozzi, Patrick G. Johnston, E Simmoncini et al.|Journal of Clinical Oncology|1997Cited by 124
Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancerRichard Turkington, Patrick G. Johnston|Cell Death and Disease|2014Cited by 96